Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroblastoma | 6 | 2022 | 57 | 2.170 |
Why?
|
| N-Myc Proto-Oncogene Protein | 3 | 2022 | 11 | 1.470 |
Why?
|
| Diethylhexyl Phthalate | 2 | 2016 | 6 | 0.970 |
Why?
|
| Uterus | 2 | 2016 | 31 | 0.950 |
Why?
|
| Eye Proteins | 2 | 2019 | 207 | 0.650 |
Why?
|
| Plasticizers | 2 | 2016 | 4 | 0.620 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 270 | 0.560 |
Why?
|
| Ovary | 1 | 2015 | 72 | 0.450 |
Why?
|
| Lactation | 1 | 2015 | 77 | 0.440 |
Why?
|
| Polyphenols | 2 | 2019 | 18 | 0.280 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 415 | 0.260 |
Why?
|
| Rats, Wistar | 2 | 2016 | 153 | 0.240 |
Why?
|
| Disease Progression | 4 | 2020 | 481 | 0.230 |
Why?
|
| Prognosis | 3 | 2022 | 815 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2022 | 472 | 0.200 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2022 | 10 | 0.180 |
Why?
|
| Animals | 6 | 2019 | 10756 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 556 | 0.180 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 51 | 0.180 |
Why?
|
| Humans | 11 | 2022 | 29078 | 0.170 |
Why?
|
| Mouth Neoplasms | 1 | 2022 | 64 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 93 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1360 | 0.170 |
Why?
|
| AC133 Antigen | 1 | 2020 | 7 | 0.170 |
Why?
|
| Antigens, CD34 | 1 | 2020 | 14 | 0.170 |
Why?
|
| Antigens, Surface | 1 | 2020 | 39 | 0.160 |
Why?
|
| Aquatic Organisms | 1 | 2019 | 6 | 0.150 |
Why?
|
| Formaldehyde | 1 | 2019 | 11 | 0.150 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 14 | 0.150 |
Why?
|
| Gene Amplification | 1 | 2019 | 23 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2019 | 81 | 0.150 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 75 | 0.150 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 303 | 0.140 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 465 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 525 | 0.130 |
Why?
|
| Phaeophyta | 1 | 2017 | 5 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2019 | 902 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2017 | 68 | 0.130 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 29 | 0.130 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 17 | 0.120 |
Why?
|
| Organ Size | 1 | 2016 | 88 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1522 | 0.120 |
Why?
|
| Estrogen Receptor beta | 1 | 2016 | 14 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2016 | 29 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 27 | 0.120 |
Why?
|
| Progesterone | 1 | 2016 | 130 | 0.120 |
Why?
|
| Estradiol | 1 | 2016 | 176 | 0.120 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 16 | 0.120 |
Why?
|
| Body Weight | 1 | 2016 | 253 | 0.110 |
Why?
|
| Curcumin | 1 | 2015 | 69 | 0.110 |
Why?
|
| Mice | 3 | 2019 | 4845 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 148 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 612 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2016 | 668 | 0.100 |
Why?
|
| Age Factors | 1 | 2015 | 740 | 0.100 |
Why?
|
| Female | 4 | 2020 | 15740 | 0.100 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 165 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2016 | 303 | 0.090 |
Why?
|
| Rats | 1 | 2015 | 1594 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 484 | 0.080 |
Why?
|
| Seaweed | 2 | 2019 | 6 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 191 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2022 | 19 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 23 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 79 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2022 | 171 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 1482 | 0.040 |
Why?
|
| Acetates | 1 | 2019 | 45 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 141 | 0.040 |
Why?
|
| Pediatrics | 1 | 2020 | 117 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 827 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 333 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 123 | 0.040 |
Why?
|
| Cell Survival | 1 | 2019 | 420 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2017 | 22 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2017 | 43 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 242 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 32 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 1056 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1201 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2017 | 63 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 202 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 66 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 276 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 781 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 34 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 267 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 171 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 53 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 377 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 191 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 477 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 239 | 0.030 |
Why?
|
| Retina | 1 | 2017 | 445 | 0.030 |
Why?
|
| Risk Factors | 1 | 2016 | 2138 | 0.020 |
Why?
|
| Male | 1 | 2020 | 14049 | 0.010 |
Why?
|